J-Pharma Co (TSE:520A) Other Current Liabilities: 円410.75 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:520A J-Pharma Co Ltd TSE:520A
9 GF Score
Price 円284.00
View Full Analysis

What is J-Pharma Co Other Current Liabilities?

J-Pharma Co TSE:520A +3.65% 9 Other Current Liabilities is 円410.75 Mil as of Dec. 2025. GuruFocus rates TSE:520A with a GF Score™ of 9/100.

J-Pharma Co's other current liabilities for the quarter that ended in Dec. 2025 was 円410.75 Mil.

J-Pharma Co's quarterly other current liabilities increased from Mar. 2024 (円51.91 Mil) to Mar. 2025 (円297.98 Mil) and increased from Mar. 2025 (円297.98 Mil) to Dec. 2025 (円410.75 Mil).

J-Pharma Co's annual other current liabilities increased from . 20 (円0.00 Mil) to Mar. 2024 (円51.91 Mil) and increased from Mar. 2024 (円51.91 Mil) to Mar. 2025 (円297.98 Mil).

J-Pharma Co Other Current Liabilities Related Terms

J-Pharma Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for J-Pharma Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

J-Pharma Co Other Current Liabilities Chart

J-Pharma Co Annual Data
Trend Mar24 Mar25
Other Current Liabilities
51.91 297.98

J-Pharma Co Quarterly Data
Mar24 Mar25 Dec25
Other Current Liabilities 51.91 297.98 410.75
TSE:520A
9GF Score
J-Pharma Co Ltd TSE:520A
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

J-Pharma Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円410.75 Mil mean?
J-Pharma Co (TSE:520A) has a Other Current Liabilities of 円410.75 Mil as of Dec. 2025. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on J-Pharma Co.
Is J-Pharma Co's Other Current Liabilities too high?
J-Pharma Co's current Other Current Liabilities is 円410.75 Mil. Overall, J-Pharma Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does J-Pharma Co's Other Current Liabilities compare to VRTX and REGN?
J-Pharma Co's Other Current Liabilities of 円410.75 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Biotechnology company?
A good Other Current Liabilities depends on the Biotechnology industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on J-Pharma Co. J-Pharma Co's current Other Current Liabilities is 円410.75 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is J-Pharma Co stock overvalued right now?
J-Pharma Co (TSE:520A) has a current Other Current Liabilities of 円410.75 Mil. The current Other Current Liabilities is 円410.75 Mil. J-Pharma Co's overall GF Score™ is 9/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For J-Pharma Co (TSE:520A), the current Other Current Liabilities is 円410.75 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

J-Pharma Co Business Description

Address 1-10-11, HamamatsuCho, 8th floor, Minato-Ku, Tokyo, JPN, 105-0013
J-Pharma Co Ltd is engaged in the Drug discovery and development targeting SLC transporters. It is focused on a single segment of the drug discovery business, focusing on R&D and clinical development. The company's two compounds in clinical development are Nanbran Latte (JPH203) and JPH034.
9GF Score

Get the complete analysis for TSE:520A

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円284.00
Price